Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats - Wikidata - wikimedia - TriplyDB

Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats

Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats

http://www.wikidata.org/entity/Q28196602

about

Aspirin in the Chemoprevention of Colorectal Neoplasia: An Overview Statin use and colorectal adenoma risk: results from the adenoma prevention with celecoxib trial.Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin.Cholesterol and benign prostate disease.Exploiting the critical perioperative period to improve long-term cancer outcomes The use of animal models for cancer chemoprevention drug development Colorectal cancer risk in relation to antidepressant medication use.Statin use is associated with a reduced incidence of colorectal cancer: a colonoscopy-controlled case-control study.Multitargeted low-dose GLAD combination chemoprevention: a novel and promising approach to combat colon carcinogenesis.Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells.Inhibitory effect of dietary atorvastatin and celecoxib together with voluntary running wheel exercise on the progression of androgen-dependent LNCaP prostate tumors to androgen independence Chemoprevention of colon cancer in a rat carcinogenesis model using a novel nanotechnology-based combined treatment system.Statin use and colorectal cancer risk according to molecular subtypes in two large prospective cohort studies.Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats.Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention.Statin use and the risk of colorectal adenoma: A meta-analysis.Celecoxib inhibits growth of human autosomal dominant polycystic kidney cyst-lining epithelial cells through the VEGF/Raf/MAPK/ERK signaling pathway Atorvastatin inhibits pancreatic carcinogenesis and increases survival in LSL-KrasG12D-LSL-Trp53R172H-Pdx1-Cre mice.Lipoxygenase and Cyclooxygenase Pathways and Colorectal Cancer Prevention N-Acetylcysteine enhances the lung cancer inhibitory effect of epigallocatechin-3-gallate and forms a new adduct Chemoprevention of colorectal cancer: two steps forward, one step back?Reversibility of aberrant global DNA and estrogen receptor-alpha gene methylation distinguishes colorectal precancer from cancer.Assessing intraepithelial neoplasia and drug safety in cancer-preventive drug development.Statins and colorectal cancer.Non-steroidal anti-inflammatory drugs and statins in relation to colorectal cancer risk.Inhibition of azoxymethane-induced colorectal cancer by CP-31398, a TP53 modulator, alone or in combination with low doses of celecoxib in male F344 rats.Important molecular genetic markers of colorectal cancer.Inhibition of IL-6 expression in LNCaP prostate cancer cells by a combination of atorvastatin and celecoxib.Synergistic chemopreventive effects of nobiletin and atorvastatin on colon carcinogenesis.Inhibition of peroxynitrite-mediated DNA strand cleavage and hydroxyl radical formation by aspirin at pharmacologically relevant concentrations: implications for cancer intervention CAAX-box protein, prenylation process and carcinogenesis.Aspirin alone and combined with a statin suppresses eicosanoid formation in human colon tissue.Colon cancer: preventive agents and the present status of chemoprevention

P2860

Q22306433-2BF49C54-658E-442D-A961-A2B93A14034C Q30497454-9474E28D-50C6-4B9C-8890-46622F718147 Q33579568-FB86A37E-EFA0-4F72-BB9C-920394A1B20D Q33716515-702D3AD2-063E-43A4-ACDF-37DAECB19D9C Q33732687-072D5905-26F0-44E6-92DB-94DDB136D89B Q33871661-473696A2-5A6E-4587-9E0E-7D1529237781 Q34112475-1AEA29F3-4512-464C-BD8E-00763D52CC18 Q34234319-0A6B072D-A357-43D3-B99A-7E19EF7C6053 Q34244183-B1993053-0D33-4DF1-BF13-185620959A2E Q34342182-F93294F4-4E04-402B-8587-8A1B552D2289 Q34687592-75236E6C-B86A-4ECD-9695-AF0BB56CF0DF Q35030507-A4C32DAF-7168-47E0-A08B-27F30A5A18C7 Q35281645-12B9225E-1107-48B9-8787-B5F9A8287543 Q35332074-20CBD5A6-FBBF-4BD3-979F-AD967F147009 Q35522954-37E9420C-E57F-4AD5-A257-8A9B2DAC338E Q35529238-1B76527B-F75F-4658-B495-76A1BBFC1DB6 Q35979411-B5CC65C0-2BC4-41CC-8A59-2DF4AB45909F Q35981512-B8809ABE-1CA7-461B-A5FC-78542CB792A3 Q36139997-0D437AFB-9FCD-4F9C-B58C-F3660BAAA6E5 Q36503568-23C0CF3D-DB9F-406B-A967-A586A4D8303F Q36631267-B377A5E9-7C40-40A6-8E59-75010BCA21D6 Q36677468-19024956-4D39-41F5-8466-9102C852FFA8 Q36800212-B3540CC5-0E73-46EF-9468-3A71E644C586 Q36849332-256820FB-2E85-4E0C-AC36-D59661187D83 Q36988768-AEAC9B53-9CCC-4AC6-9A2A-847FC0F6BA77 Q37198299-FE1E99E9-B3EC-45E9-832F-00E8F6C2FE6B Q37473855-70FFF654-6DE8-450D-B8B3-1B0CCEA8BC5F Q37619856-631E6AD7-24FF-447F-B955-2E0B3058DEE9 Q37694029-244CEF28-1478-4A92-9E7C-E6296924A25B Q38716191-5D6B5719-2E4B-4BDF-844E-C795C7DC9933 Q41770255-024F1AD3-B4FA-453E-A8A1-A564BC847CF8 Q42069148-4FB93399-B9A5-4391-8B96-EC2304037FB2 Q52809890-862723BD-BCBD-4881-9797-431C1662B862 Q54172424-6407CC1A-C10A-4F8B-B22B-D1835FD472D0

P2860

Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats

http://www.wikidata.org/entity/Q28196602

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@ast

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@en

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@nl

type

label

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@ast

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@en

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@nl

prefLabel

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@ast

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@en

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@nl

P1433

Q28196602-57517252-54D1-4801-BCDC-2B8DA36E2C68

P1476

Q28196602-A329DDF0-22EB-43E2-A302-EAEC4D878A23

P2093

Q28196602-48D879E9-9DFB-42FA-800F-0ABC80893324

Q28196602-9E280816-A58C-4ECE-8C18-565DDE4E7537

Q28196602-A767EB1D-3FE4-4E8C-B883-3004EB601795

Q28196602-A77B7A6F-8531-4D3F-BEB7-216B434D9029

Q28196602-C8D3B2B0-1A3C-4C86-8270-F6DAB00C83A6

Q28196602-CD155F7E-BC95-4495-9DEB-7CACAF1622F5

Q28196602-E71B0CDE-5F01-4392-8015-16A82DB40DE3

Q28196602-F5E4E0F3-4DCF-4C4C-9546-75B96CDEC38F

P304

Q28196602-5E895844-4F66-47B6-9217-5549EE7A9348

P31

Q28196602-108A8E6F-8CB6-4FFA-87B6-203B2F5CB83E

P3181

Q28196602-98BC7B65-6706-4323-8FE6-41B977E5B4A7

P356

Q28196602-76FC9EDF-3C27-4B5C-A347-51009D2D4AD4

P407

Q28196602-78F5212E-6BE9-4C68-8109-FB311408A932

P433

Q28196602-9C24EA68-E01B-493D-B5D7-F4F71104456D

P478

Q28196602-1D75460B-5ECE-481B-82DB-23D6BACDF37B

P577

Q28196602-82247412-AF1A-4174-91D8-25D7ED8A426D

P5875

Q28196602-576CACAF-F1E7-42D7-893D-2A93E752EE34

P698

Q28196602-3147DD30-D05F-443E-8AAA-9264FB842250

P921

Q28196602-EBCA478A-926D-4E62-B40D-9772760A3F37

P3181

P356

0008-5472.CAN-05-4428

P1433

Cancer Research

P1476

Prevention of azoxymethane-ind ...... n, and celecoxib in F 344 rats

@en

P2093

Ah-Ng Kong

http://www.w3.org/2001/XMLSchema#string

Bandaru S Reddy

http://www.w3.org/2001/XMLSchema#string

Chinthalapally V Rao

http://www.w3.org/2001/XMLSchema#string

Chung Xiou Wang

http://www.w3.org/2001/XMLSchema#string

Levy Kopelovich

http://www.w3.org/2001/XMLSchema#string

Tin Oo Khor

http://www.w3.org/2001/XMLSchema#string

Vernon E Steele

http://www.w3.org/2001/XMLSchema#string

Xi Zheng

http://www.w3.org/2001/XMLSchema#string

P304

4542-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4798830

http://www.w3.org/2001/XMLSchema#string

P356

10.1158/0008-5472.CAN-05-4428

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

66

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7161032

http://www.w3.org/2001/XMLSchema#string

P698

16618783

http://www.w3.org/2001/XMLSchema#string

P921